Flow Cytometry-Guided Diagnosis of Cortical T-Lymphoblastic Lymphoma Presenting With a Massive Mediastinal Mass and Borderline Bone Marrow Involvement.

IF 2.5 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY
Chen Glait-Santar, Yakir Moshe, Itzhaki-Alfia Ayelet, Ben-Zion Katz
{"title":"Flow Cytometry-Guided Diagnosis of Cortical T-Lymphoblastic Lymphoma Presenting With a Massive Mediastinal Mass and Borderline Bone Marrow Involvement.","authors":"Chen Glait-Santar, Yakir Moshe, Itzhaki-Alfia Ayelet, Ben-Zion Katz","doi":"10.1002/jcla.70369","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>T-cell lymphoblastic lymphoma (T-LBL) and T-cell acute lymphoblastic leukemia (T-ALL) are considered a single biological entity, distinguished primarily by the extent of bone marrow infiltration. This distinction becomes diagnostically challenging in patients with borderline marrow blast counts and predominantly extramedullary disease, risking overclassification as leukemia.</p><p><strong>Methods: </strong>We describe a 57-year-old man who presented with dyspnea and a large mediastinal mass causing superior vena cava syndrome, with pleural and pericardial effusions. Diagnostic workup included complete blood count and biochemistry, imaging, fine-needle aspiration, core biopsy, pleural fluid cytology, multiparameter flow cytometry of pleural fluid and bone marrow, immunohistochemistry, and cerebrospinal fluid analysis.</p><p><strong>Results: </strong>CBC and biochemistry were largely unremarkable aside from elevated LDH and CRP. Cytology and biopsy showed a diffuse blastoid lymphoid infiltrate. Pleural fluid flow cytometry identified an aberrant immature T-cell population (cytoplasmic CD3+, CD1a+, CD2+, CD4+, CD5(dim)+, CD7+, CD8+, CD10+, TdT+; surface CD3-, CD34-, MPO-), confirming cortical T-ALL/LBL and excluding B- and myeloid-lineage differentiation. Bone marrow morphology suggested ~10% blasts, but flow cytometry detected only 3.8% CD34+ cells with a myeloid-skewed, non-T-lymphoblastic phenotype, arguing against significant marrow involvement. The patient was classified as T-LBL and treated per the GMALL protocol, achieving complete remission.</p><p><strong>Conclusion: </strong>Flow cytometry resolved a discrepancy between morphologic and immunophenotypic assessment of bone marrow involvement, preventing overclassification as T-ALL. Multiparameter flow cytometry is essential for accurate lineage assignment and staging of precursor T-lymphoid neoplasms in cytologic specimens and borderline marrow samples.</p>","PeriodicalId":15509,"journal":{"name":"Journal of Clinical Laboratory Analysis","volume":" ","pages":"e70369"},"PeriodicalIF":2.5000,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13624735/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Laboratory Analysis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jcla.70369","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: T-cell lymphoblastic lymphoma (T-LBL) and T-cell acute lymphoblastic leukemia (T-ALL) are considered a single biological entity, distinguished primarily by the extent of bone marrow infiltration. This distinction becomes diagnostically challenging in patients with borderline marrow blast counts and predominantly extramedullary disease, risking overclassification as leukemia.

Methods: We describe a 57-year-old man who presented with dyspnea and a large mediastinal mass causing superior vena cava syndrome, with pleural and pericardial effusions. Diagnostic workup included complete blood count and biochemistry, imaging, fine-needle aspiration, core biopsy, pleural fluid cytology, multiparameter flow cytometry of pleural fluid and bone marrow, immunohistochemistry, and cerebrospinal fluid analysis.

Results: CBC and biochemistry were largely unremarkable aside from elevated LDH and CRP. Cytology and biopsy showed a diffuse blastoid lymphoid infiltrate. Pleural fluid flow cytometry identified an aberrant immature T-cell population (cytoplasmic CD3+, CD1a+, CD2+, CD4+, CD5(dim)+, CD7+, CD8+, CD10+, TdT+; surface CD3-, CD34-, MPO-), confirming cortical T-ALL/LBL and excluding B- and myeloid-lineage differentiation. Bone marrow morphology suggested ~10% blasts, but flow cytometry detected only 3.8% CD34+ cells with a myeloid-skewed, non-T-lymphoblastic phenotype, arguing against significant marrow involvement. The patient was classified as T-LBL and treated per the GMALL protocol, achieving complete remission.

Conclusion: Flow cytometry resolved a discrepancy between morphologic and immunophenotypic assessment of bone marrow involvement, preventing overclassification as T-ALL. Multiparameter flow cytometry is essential for accurate lineage assignment and staging of precursor T-lymphoid neoplasms in cytologic specimens and borderline marrow samples.

以纵隔肿块和交界性骨髓浸润为表现的皮质t淋巴母细胞淋巴瘤的流式细胞术指导诊断。
背景:t细胞淋巴母细胞淋巴瘤(T-LBL)和t细胞急性淋巴母细胞白血病(T-ALL)被认为是一种单一的生物实体,主要通过骨髓浸润的程度来区分。这种区分在骨髓母细胞计数呈边缘性且主要为髓外疾病的患者中变得具有诊断挑战性,有被过度分类为白血病的风险。方法:我们描述了一位57岁的男性,他表现为呼吸困难和一个大纵隔肿块引起上腔静脉综合征,并伴有胸膜和心包积液。诊断检查包括全血细胞计数和生化、影像学、细针穿刺、核心活检、胸膜液细胞学、胸膜液和骨髓多参数流式细胞术、免疫组织化学和脑脊液分析。结果:除LDH和CRP升高外,CBC和生化指标基本无明显变化。细胞学和活检显示弥漫性囊胚样淋巴浸润。胸膜液流式细胞术检测到异常的未成熟t细胞群(细胞质CD3+、CD1a+、CD2+、CD4+、CD5(dim)+、CD7+、CD8+、CD10+、TdT+);表面CD3-, CD34-, MPO-),证实皮质T-ALL/LBL,排除B-和髓系分化。骨髓形态学显示约10%为母细胞,但流式细胞术仅检测到3.8%的CD34+细胞具有骨髓倾斜的非t淋巴细胞表型,这表明骨髓不存在明显的病变。患者被分类为T-LBL并按照GMALL方案治疗,达到完全缓解。结论:流式细胞术解决了骨髓受累的形态学和免疫表型评估之间的差异,防止了T-ALL的过度分类。多参数流式细胞术对于细胞学标本和交界性骨髓样本中前体t淋巴样肿瘤的准确谱系分配和分期至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Laboratory Analysis
Journal of Clinical Laboratory Analysis 医学-医学实验技术
CiteScore
5.60
自引率
7.40%
发文量
584
审稿时长
6-12 weeks
期刊介绍: Journal of Clinical Laboratory Analysis publishes original articles on newly developing modes of technology and laboratory assays, with emphasis on their application in current and future clinical laboratory testing. This includes reports from the following fields: immunochemistry and toxicology, hematology and hematopathology, immunopathology, molecular diagnostics, microbiology, genetic testing, immunohematology, and clinical chemistry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书